Vimarsana
Biggest News Aggregation in the World

Strides Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Strides Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Strides Pharma Today - Breaking & Trending Today

USFDA Grants Approval To Strides Pharma For Generic GERD Treatment Formulation - Vimarsana News

USFDA Grants Approval To Strides Pharma For Generic GERD Treatment Formulation

Moreover, Strides Pharma’s ambitious plans to launch approximately 60 new products in the US over the next three years further underscore its commitment to portfolio diversification and expansion. This forward-looking approach aligns with the company’s overarching objective of bolstering its market presence and addressing evolving healthcare needs. - Newsx

Source: newsx.com
Startup news and updates: daily roundup (May 21, 2024) - Vimarsana News

Startup news and updates: daily roundup (May 21, 2024)

YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Tuesday, May 21, 2024.

Deep tech startup 8chili receives investment to lead way for healthcare workforce training - Vimarsana News

Deep tech startup 8chili receives investment to lead way for healthcare workforce training

Deep tech startup 8chili receives investment to lead way for healthcare workforce training

KonProz, 8chili raise early-stage funding; Venture Catalysts bets on healthtech platform - Vimarsana News

KonProz, 8chili raise early-stage funding; Venture Catalysts bets on healthtech platform

Generative artificial intelligence startup KonProz, healthtech startup Humors Tech and deeptech startup 8chili secured early-stage funding, the companies said on Monday. KonProz Generative AI startup KonProz has ......

Indian pharma industry to witness 11% rise in revenues, propelled by domestic and US markets: Sharekhan Report - Vimarsana News

Indian pharma industry to witness 11% rise in revenues, propelled by domestic and US markets: Sharekhan Report

It says Ebitda margins may reach 24.9%, boosted by product mix and cost control; long-term growth outlook positive, focused on complex products, domestic demand, and R&D investments